12. Post Intubation Management
• ミダゾラム、プロポフォール、デクスメデトミジ
ン(プレセデックス)持続投与を用いて鎮静。
• フェンタニル持続投与を用いて鎮痛。
上記を行い、病棟での気管挿管管理となる。
13. Rapid sequence induction and intubation with rocuronium-
sugammadex compared with succinylcholine: a randomized trial.
Br J Anaesth. 2012 Apr;108(4):682-9.
• Succinylcholine
VS Rocuronium + Sugammadex
• Methods
Pre-oxygenationを行い、Alfentanil (10 µg/kg), Propofol (2 mg/kg)を用いて
Propofol持続投与(3mg/kg/hr)を行った。
その後、Succinylcholine (1 mg/kg)群とRocuronium (1 mg/kg)群に分け、筋弛緩を
行った。
Rocuronium群では気管挿管後にSugammadex (16 mg/kg)を投与した。
The primary endpoint
the time from correct placement of the tracheal tube to spontaneous ventilation,
defined as a respiratory rate of more than 8 bpm and a tidal volume of at least 3
ml/kg for 30 seconds.
Secondary outcomes
Duration of action of NMBA measured with TOF-Watch SX® from start of injection
of the NMBA to recovery of T1 in TOF to above 90% (T1 90%) and from tracheal
intubation to recovery of T1 to 90%.
14. • RESULTS:
55名が解析対象
The primary endpoint
The median time from tracheal intubation to spontaneous ventilation was
406 s with succinylcholine and 216 s with rocuronium-sugammadex (P = 0.002).
The secondary outcome
The median time from tracheal intubation to 90% recovery of the first twitch in
train-of-four (T(1) 90%) was 518 s with succinylcholine and
168 s with rocuronium-sugammadex (P < 0.0001).
Intubation conditions and time to tracheal intubation were not significantly
different.
• CONCLUSIONS:
RSII with rocuronium followed by reversal with sugammadex allowed earlier re-
establishment of spontaneous ventilation than with succinylcholine.